Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4020-4032
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4020
Table 1 MDCT scan parameters
Group
Scan protocol/parameters
Scan areaFrom diaphragm top to lower edge of symphysis pubis
Body positionSupine position
Tube voltage (kV)/tube current (mAs)120/care dose 4D
Linear fusion coefficient0.5
Pitch1.0
Rotate speed0.5 s
Collimation (mm)2 × 192 × 0.6
Thickness of collection layer (mm)1 mm
Interlayer spacing0.6 mm
Convolution kernelBr40
Enhancement protocolArterial phase (automatic tracking technology: when the aortic monitoring threshold reached 100 HU, the arterial phase scan was triggered); intravenous phase (scan started 75 s after the contrast agent was injected)
Contrast agent (concentration)Iopromide (370 mgI/mL)
Dose and rate of contrast agent administration1.5 mL/kg, 3.5 mL/s
Table 2 The demographic characteristics of death and survival groups

Total number (n = 53)
Survival group (n = 44)
Death group (n = 9)
P value
Sex (%)0.938
Male33 (62.3)28 (52.8)5 (9.4)
Female20 (37.7)16 (30.2)4 (7.5)
Smoking (%)1.000
No35 (66.0)29 (54.7)6 (11.3)
Yes18 (34.0)15 (28.3)3 (5.7)
Alcohol (%)0.667
No35 (66.0)28 (52.8)7 (13.2)
Yes18 (34.0)16 (30.2)2 (3.8)
Diabetes (%)0.978
No44 (83.0)36 (67.9)8 (15.1)
Yes9 (17.0)8 (15.1)1 (1.9)
Hypertension (%)1.000
No27 (50.9)22 (41.5)5 (9.4)
Yes26 (49.1)22 (41.5)4 (7.5)
Heart disease (%)1.000
No26 (49.1)22 (41.5)4 (7.5)
Yes27 (50.9)22 (41.5)5 (9.4)
Surgery (%)0.395
No38 (71.7)30 (56.6)8 (15.1)
Yes15 (28.3)14 (26.4)1 (1.9)
Vomitus (%)0.938
No20 (37.7)16 (30.2)4 (7.5)
Yes33 (62.3)28 (52.8)5 (9.4)
Age (yr)74 (63.50, 80.50)72 (62.25, 80.00)75 (73.00, 82.00)0.231
Abdominal pain duration (d)1.00 (1.00, 5.00)2.00 (1.00, 5.00)1.00 (0.75, 2.00)0.298
Body temperature at admission (℃)36.7 (36.5, 37.7)36.6 (36.4, 37.3)37.7 (36.6, 38.4)0.055
Table 3 Biochemical indicators of death and survival groups

Total number (n = 53)
Survival group (n = 44)
Death group (n = 9)
P value
D-dimer > 1000 μg/mL (%)0.499
No20 (37.7)18 (34.0)2 (3.8)
Yes33 (62.3)26 (49.1)7 (13.2)
Blood lactate > 2.1 mmol/L (%)0.004
No44 (83.0)40 (75.5)4 (7.5)
Yes9 (17.0)4 (7.5)5 (9.4)
Blood pH < 7.35 (%)0.004
No47 (88.7)42 (79.2)5 (9.4)
Yes6 (11.3)2 (3.8)4 (7.5)
Blood amylase > 110 U/L (%)0.027
No32 (84.2)29 (76.3)3 (7.9)
Yes6 (15.8)3 (7.9)3 (7.9)
Serum creatinine > 120 μmol/L (%)0.097
No36 (78.3)32 (69.6)4 (8.7)
Yes10 (21.7)6 (13.0)4 (8.7)
White blood cell10.6 (6.95, 15.45)9.1 (6.73, 16.48)10.7 (9.2, 14.6)0.362
Red blood cell4.19 (3.89, 4.64)4.18 (3.97, 4.63)4.48 (3.60, 4.94)0.887
Neutrophil8.5 (5.42, 13.66)7.55 (5.36, 14.46)9.42 (7.75, 12.90)0.236
Lymphocyte0.9 (0.6, 1.2)0.90 (0.60, 1.20)0.70 (0.55, 1.20)0.392
Neutrophil/lymphocyte9.3 (6.00, 16.22)8.47 (5.48, 16.42)13.46 (8.52, 17.33)0.169
Total protein64.4 (56.55, 70.85)64.2 (56.73, 69.45)67.0 (51.3, 76.05)0.713
Albumin to total protein ratio1.20 (1.0, 1.3)1.20 (1.00, 1.38)1.10 (1.00, 1.30)0.516
Blood glucose6.90 (5.65, 8.44)6.8 (4.93, 8.44)7.70 (6.90, 16.28)0.107
Table 4 Comparison of multidetector computed tomography reading results of two radiologists

Total number
A
B
P value
Embolus involvement length (%)
≤ 20 mm146130.014
20-50 mm1110111
≥ 50 mm2825280.236
Embolus region (%)
I5451
II1111
III2020.024
IV837
I + II2221
III + IV1918191
I + II + III1111
II + III + IV7671
I + II + III + IV8881
Extravascular signs (%)
Decreased intestinal wall enhancement3024280.255
Intestinal wall thinning229140.131
Intestinal wall thickening1414141
Pneumatosis intestinalis5331
Infarction of the organs2218220.108
Mesenteric fat stranding2925270.67
Table 5 Comparison of multidetector computed tomography signs in death and survival groups

Survival group (n = 44)
Death group (n = 9)
P value
Embolus involvement length (%)0.311
≤ 20 mm12 (27.27)1 (11.11)
20-50 mm10 (22.73)1 (11.11)
≥ 50 mm22 (50.00)7 (77.78)
Embolus region (%)0.212
I4 (9.09)1 (11.11)
II1 (2.27)0 (0)
III2 (4.55)0 (0)
IV8 (18.18)0 (0)
I + II1 (2.27)1 (11.11)
III + IV17 (38.64)2 (22.22)
I + II + III1 (2.27)0 (0)
II + III + IV 6 (13.64)1 (11.11)
I + II + III + IV4 (9.09)4 (44.44)
Decreased intestinal wall enhancement (%)0.004
No23 (52.27)0 (0)
Yes21 (47.73)9 (100)
Intestinal wall thinning (%)0.002
No30 (68.18)1 (11.11)
Yes14 (31.82)8 (88.89)
Intestinal wall thickening (%)0.178
No34 (77.27)5 (55.56)
Yes10 (22.73)4 (44.44)
Pneumatosis intestinalis (%)0.007
No42 (95.45)6 (66.67)
Yes2 (4.55)3 (33.33)
Infarction of other organs (%)0.348
No27 (61.36)4 (44.44)
Yes17 (38.64)5 (55.56)
Mesenteric fat stranding (%)0.127
No22 (50)2 (22.22)
Yes22 (50)7 (77.78)
Table 6 Univariate cox regression

HR
95%CI
P value
Intestinal wall thinking2.27(0.61-8.45)0.223
Intestinal wall thinning13.35(1.54-99.01)0.018
Pneumatosis intestinalis5.73(1.41-23.35)0.015
Other organ infarction1.79(0.48-6.67)0.386
mesenteric fat stranding2.96(0.62-14.27)0.176
Blood lactate > 2.1 mmol/L6.82(1.82-25.60)0.004
Blood pH < 7.357.36(1.94-27.86)0.003
Embolus distribution region (multi-classification variable)1.42(0.92-1.74)0.156
Embolus involvement length
20-50 mm (vs ≤ 20 mm)1.09(0.07-17.50)0.951
≥ 50 mm (vs ≤ 20 mm)3.14(0.39-25.54)0.284
Table 7 Multivariate cox regression
Model1
Model2
Model3

HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
Intestinal wall thinning9.40(1.05-83.46)0.0449.66(1.15-81.03)0.03711.01(1.32-92.22)0.027
Pneumatosis intestinalis4.58(0.86-24.36)0.0746.09(1.25-29.69)0.0256.01(1.25-28.97)0.025
Blood lactate > 2.1 mmol/L5.26(1.04-26.69)0.0455.21(1.12-24.22)0.0356.34(1.56-25.73)0.010
Blood pH < 7.354.84(0.94-25.09)0.0605.59(1.26-24.88)0.0246.26(1.47-26.59)0.013